Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Companies

Top Ten Companies // Browse A - Z of companies

  • Merck KGaA (Merck)
  • Merck (Merck KGaA)
  • Pfizer
  • Roche
  • Novartis
  • GlaxoSmithKline (GSK)
  • GSK (GlaxoSmithKline)
  • Bristol-Myers Squibb
  • Lilly
  • Bayer

Browse the A - Z of Companies

  • #
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

L

  • Lab Clausen
  • Lab Teuto Brasileiro
  • LabCorp
  • Labopharm
  • Laboratoire francais du Fractionnement et des Biotechnologies
  • Laboratoires Majorelle
  • Laboratoires SERB
  • Laboratoires SMB
  • Laboratoires Thea
  • Laboratorios Cinfa
  • Laboratorios Gautier
  • Laboratorios Phoenix
  • Laboratorios SALVAT
  • Labormed Pharmaceuticals
  • LadaTech
  • Lanthio Pharma
  • Laser SA
  • Lectus Therapeutics
  • Lee's Pharmaceutical
  • Lentigen
  • LEO Pharma
  • Leo Pharmaceutical Products
  • Leoni Studer
  • Lexicon Pharmaceuticals
  • LFB Biotechnologies
  • Life Sciences Entrepreneurs
  • Life Technologies
  • Ligand Pharmaceuticals
  • LigoCyte
  • LigoCyte Pharmaceuticals
  • Lilly
  • Limerick Bioscience
  • Link Medicines
  • Lipoxen
  • Liquidia Technologies
  • Litha Healthcare
  • LoneStar Heart
  • Lonza
  • Lotus Tissue Repair
  • Lpath
  • LTS
  • Luitpold Pharma
  • Luminex
  • Lundbeck
  • Lundbeckfond
  • Lupin
  • Lux Biosciences
  • Lux Research
  • Luye Pharma
  • Lycera Corp
  • Hot Topics
  • Most Read
  • Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • It's official: "obesity is a disease," says AMA
  • Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
  • Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
  • It's official: "obesity is a disease," says AMA
  • Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS